SIRT3 and metabolic dysfunction-associated steatotic liver disease: A previous study found that the expression of SIRT1, SIRT3, SIRT5, and SIRT6 in NAFLD is decreased, while the expression of SIRT4 is upregulated, which may promote the progress of NAFLD [156].